A detailed history of Colonial Trust CO / Sc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Colonial Trust CO / Sc holds 32 shares of LNTH stock, worth $1,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32
Previous 37 13.51%
Holding current value
$1,696
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$50.11 - $83.83 $250 - $419
-5 Reduced 13.51%
32 $1,000
Q2 2025

Aug 13, 2025

BUY
$73.86 - $108.74 $221 - $326
3 Added 8.82%
37 $3,000
Q1 2025

May 13, 2025

BUY
$78.23 - $110.01 $1,016 - $1,430
13 Added 61.9%
34 $3,000
Q4 2024

Feb 14, 2025

SELL
$76.22 - $116.71 $1,067 - $1,633
-14 Reduced 40.0%
21 $1,000
Q3 2024

Nov 12, 2024

BUY
$77.7 - $123.62 $2,719 - $4,326
35 New
35 $3,000
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $1,668 - $2,336
30 New
30 $1,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $3.64B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.